Related Articles
Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: Implications for MMP inhibition therapy
Comparative gene expression profiling of ADAMs, MMPs, TIMPs, EMMPRIN, EGF-R and VEGFA in low grade meningioma
Role of SGLT1 in high glucose level-induced MMP-2 expression in human cardiac fibroblasts
Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer
Dynamic features of liver fibrogenesis and fibrosis resolution in the absence of matrix metalloproteinase‑9